Global Point of Care/ At - Home Thyroid Diagnosis Market Research Report

 As per the research conducted by GME, the Point of Care/ At-Home Thyroid Diagnosis Market will grow with a CAGR value of 6.5 percent. The rising geriatric patient population across both developed and developing regions will also boost the demand for testing kits in the market. Also, with the increasing cases of thyroid patients, and increasing demand for point of care testing due to COVID-19 limitations on social distancing, the market for at-home thyroid diagnosis will be growing the fastest from 2021 to 2026

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Point of Care/ At-Home Thyroid Diagnosis Market- Forecast to 2026" 

https://www.globalmarketestimates.com/market-report/global-point-of-care-at---home-thyroid-diagnosis-market-2924

By Type of Biomarkers (Complete Thyroid Profiling [Free T3, T4, TSH], Thyroid Peroxidase Antibodies [TPO/TPEX], Thyroglobulin Antibodies [TGAB], and Thyrotropin-Releasing Hormone [TRH]), By Application (Hypothyroidism [Hashimoto’s Disease], Hyperthyroidism [Graves’ Disease], and Other Applications), By Patient Gender (Male & Female Patients and Only Female Patients), By Product Type (At-Home Thyroid Diagnostic Kit, and At-Home Thyroid Sample Collection Kit), By Sample Collection Technique (Finger Prick and Blood Sample), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

 Key Market Insights

·         The market for the at-home thyroid diagnostic kit will be growing faster than the collection kit owing to the advantagesof screening for the disorders at home

·         The market segment of complete thyroid profiling will possess a larger share than other segment from 2021 to 2026

·         The market for finger prick will be the largest because most of the commercialized at-home testing products offer finger prick sample collection techniques

·         Everlywell, Paloma, LetsGetChecked, Imaware, Personal Diagnostics, PRIMA Lab SA, HomeCheck, healthconfirm, CVS Pharmacy, Doctorcall, Medichecks, PlushCare, Zavamed, Valuemed, and Thriva among others are the players in the point of care/ at-home thyroid diagnosis market

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-point-of-care-at---home-thyroid-diagnosis-market-2924

Type of Biomarker Outlook (Revenue, USD Billion, 2021-2026)

·         Complete Thyroid Profiling [Free T3, T4, TSH]

·         Thyroid Peroxidase Antibodies [TPO/TPEX]

·         Thyroglobulin Antibodies [TGAB]

·         Thyrotropin-Releasing Hormone [TRH]

Application Outlook (Revenue, USD Billion, 2021-2026)

·         Hypothyroidism [Hashimoto’s Disease]

·         Hyperthyroidism [Graves’ Disease]

·         Other Applications

Patient Gender Outlook (Revenue, USD Billion, 2021-2026)

·         Male & Female Patients

·         Only Female Patients

Product Type Outlook (Revenue, USD Billion, 2021-2026)

·         At-Home Thyroid Diagnostic Kit

·         At-Home Thyroid Sample Collection Kit

Sample Collecting Technique Outlook (Revenue, USD Billion, 2021-2026)

·         Finger Prick

·         Blood Sample

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php